Statistical methods for cost-effectiveness analyses

Controlled Clinical Trials

Volumn 17, Issue 5, 1996, Pages 387-406

  Siegel, Carole ^a   Laska, Eugene ^b   Meisner, Morris ^b  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b NONE

Author keywords

benefit; cost effectiveness ratio; cost utility; cost benefit; net benefit; non responder models; preference measures

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; REGRESSION ANALYSIS; STATISTICS; THEORETICAL STUDY;

EID: 0030272252     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(95)00259-6     Document Type: Article

References (32)

1. 1. Lyons JS, Hammer JS, Wise TN, Strain JJ: Consultation-liaison psychiatry and cost-effectiveness research. A review of methods. Gen Hosp Psychiatry 7:302-305, 1985
2. 2. Adams ME, McCall NT, Gray DT, Orza MJ, Chalmers TC: Economic analysis in randomize control trials. Med Care 30:231-243, 1992
3. 3. Udvarhelyi S, Colditz GA, Rai A, Epstein AM: Cost-effectiveness and cost-benefit analysis in the medical literature. Are the methods being used correctly? Ann Intern Med 116:238-244, 1992
4. 4. O' Brien BJ, Drummond MF, Labelle RJ, Willan A: In search of power and significance: Issues in the design and analysis of stochastic cost-effectiveness studies in health care. Med Care 32:150-163, 1994
5. 5. Warner KE, Luce BR: Cost-Benefit and Cost-Effectiveness Analysis in Health Care. Ann Arbor, Health Administration Press, 1982
6. 6. Torrance GW: Measurement of health state utilities for economic appraisal. J Health Econ 5:1-30, 1986
7. 7. Weisbrod BA: A guide to benefit-cost analysis, as seen through a controlled experiment in treating the mentally ill. J Health Polit Policy Law 7:808-845, 1983
8. 8. Jerrell JM, Hu T-W: Cost-effectiveness of intensive clinical and case management compared with an existing system of care. Inquiry 26:224-234, 1989
9. 9. Newman FL, Sorenson JE: Integrated Clinical and Fiscal Management in Mental Health. A Guidebook. Norwood, NJ, Ablex, 1985
10. 10. Van Hout BA, Al MJ, Gordon GS, Rutten FF: Costs, effects and C/E ratios alongside a clinical trial. Health Econ 3:309-319, 1994
11. 11. Farewell VT: The use of mixture models for the analysis of survival data with long-term survivors. Biometrics 38:1041-1046, 1982
12. 12. Greenhouse JB, Wolfe RA: A competing risks derivation of a mixture model for the analysis of survival data. Commun Statist Theor Meth 13:3133-3154, 1984
13. 13. Laska EM, Siegel C, Sunshine A: Onset and duration: Measurement and analysis. Clin Pharmacol & Ther 49:1-5, 1991
14. 14. Siegel C, Sunshine A, Richman H, Olson NZ, Robissa N, Codone R, Estrada N, Laska E: Meptazinol and morphine in postoperative pain assessed with a new method for onset and duration. J Clin Pharmacol 29:1017-1025, 1989
15. 15. Kamlet MS, Paul N, Greenhouse J, Kupfer D, Frank E, Wade M. Cost utility analysis of maintenance treatment for recurrent depression. Controlled Clin Trials 16:17-40, 1995
16. 16. Culyer AJ: The morality of efficiency in health care - some uncomfortable implications. Health Econ 1:7-18, 1992
17. 17. Eddy MH: Clinical Decision Making: From theory to practice. Applying cost-effectiveness analysis. JAMA 268:2575-2582, 1992
18. 18. Keeney RL, Raiffa H: Decisions with Multiple Objectives: Preferences and Value Tradeoffs. New York, John Wiley, 1976
19. 19. Thompson MS: Benefit-Cost Analysis for Program Evaluation. Beverly Hills, CA, Sage, 1980
20. 20. Fishman D: Development of a generic cost-effectiveness methodology for evaluating patient services of a community mental health center. Paper presented to National Conference on Evaluation in Alcohol, Drug Abuse and Mental Health Program, Washington, DC, 1974
21. 21. Sorensen JE, Grove HD: Using cost-outcome and cost-effectiveness analyses for improved program management and accountability. In Evaluation of Human Service Programs, Attkisson CC, Hargreaves WA, Horowitz MJ, Sorensen JE, eds. New York, Academic Press, 1978
22. 22. Kotz S, Johnson NL (eds): Encyclopedia of Statistical Sciences. New York, John Wiley, 646-647, 1986
23. 23. Laska EM, Meisner M: Testing whether an identified treatment is best. Biometrics 45:1139-1151, 1989
24. 24. Laska EM, Tang D-I, Meisner M: Testing hypotheses about an identified treatment when there are multiple endpoints. J Am Stat Assoc 87:825-831, 1992
25. 25. Sobel MJ: Bayes and minimax sample-admissible multivariate selection procedures. J Am Stat Assoc 86:1022-1023, 1991
26. 26. Laska EM, Kushner HB, Meisner M: Reader Reaction. Multivariate bioassay. Biometrics 41:547-554, 1985
27. 27. Laska EM, Meisner M: Statistical methods and applications of bioassay. In Annual Review of Pharmacology and Toxicology. George R, Okun R, eds. Palo Alto, CA: Annual Reviews, 1987
28. 28. Volund A: Multivariate bioassay. Biometrics 36:225-236, 1980
29. 29. Siegel S: Nonparametric Statistics for the Behavioral Sciences. New York, McGraw-Hill, 1988
30. 30. Gibbon JD, Olkin I, Sobel M: Selecting and Ordering Populations. A New Statistical Methodology. New York, John Wiley, 1977
31. 31. Dudewicz EJ, Taneja VS: A multivariate solution of the multivariate raking and selection problem. Commun Statist Theor Meth A10, 1849-1868, 1981
32. 32. Hwang CL, Masud ASM: Multiple Objective Decision Making - Methods and Applications. A State-of-the Art Survey. Berlin, Springer-Verlag, 1979